Literature DB >> 28620754

Variation in Pediatric Post-Ablation Care: A Survey of the Pediatric and Congenital Electrophysiology Society (PACES).

Brynn E Dechert1, Macdonald Dick2, David J Bradley2, Martin J LaPage2.   

Abstract

Although catheter ablation is a standard treatment for pediatric arrhythmias, there are no consensus guidelines for follow-up care. This study describes the variation in post-ablation practices identified through a survey of the pediatric and congenital electrophysiology society (PACES). Pediatric and congenital electrophysiology society members were invited to participate in an online survey of post-ablation practices in September 2014. Survey questions targeted routine post-ablation practices for three common arrhythmia substrates: atrioventricular nodal reentry tachycardia, concealed accessory pathways (AP), and manifest APs. Significant practice variation was defined as <90% concordance among respondents. There were 70 respondents from 67 centers, 29 (41%) in practice for <10 years. Uniform practices included aspirin after left side ablation by 65 (93%), immediate post-procedure ECG by 63 (90%), and performance of outpatient follow-up in 69 (99%) including ECG in 97-100% depending on substrate. The majority, 57 (81%), have standardized follow-up independent of substrate. Post-procedural observation is highly variable, with 25 (36%) discharging patients on the day of ablation, 22 (33%) observing patients in hospital overnight, and 21 (30%) basing hospitalization on pre-defined criteria. Immediate post-procedure echo is performed after all ablations in only 16 (23%). Discharge from outpatient care occurs at a median time of 12 months for each arrhythmia substrate. Common post-ablation practices are evident among pediatric electrophysiologists. However, they report significant variation in post-procedure monitoring practices and testing. The rationale for these variances, and their impact on costs and outcomes, should be defined.

Entities:  

Keywords:  Cryoablation; Pediatrics; Post-ablation care; Radiofrequency ablation; Variation

Mesh:

Year:  2017        PMID: 28620754     DOI: 10.1007/s00246-017-1654-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

1.  Transseptal access in pediatric and congenital electrophysiology procedures: defining risk.

Authors:  Johannes C von Alvensleben; Macdonald Dick; David J Bradley; Martin J LaPage
Journal:  J Interv Card Electrophysiol       Date:  2014-11-22       Impact factor: 1.900

2.  Long-term outcomes for cryoablation of pediatric patients with atrioventricular nodal reentrant tachycardia.

Authors:  Martin J LaPage; J Philip Saul; John H Reed
Journal:  Am J Cardiol       Date:  2010-02-20       Impact factor: 2.778

3.  Atrio-ventricular conduction following radiofrequency ablation for atrio-ventricular node reentry tachycardia in children.

Authors:  Michal J Kantoch; Joseph Atallah; Reeni N Soni
Journal:  Europace       Date:  2010-04-01       Impact factor: 5.214

4.  Use of 3D Electroanatomical Navigation (CARTO-3) to Minimize or Eliminate Fluoroscopy Use in the Ablation of Pediatric Supraventricular Tachyarrhythmias.

Authors:  Lakshmi Nagaraju; Dipika Menon; Peter F Aziz
Journal:  Pacing Clin Electrophysiol       Date:  2016-03-15       Impact factor: 1.976

5.  Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardia.

Authors:  George F Van Hare; Harold Javitz; Dorit Carmelli; J Philip Saul; Ronn E Tanel; Peter S Fischbach; Ronald J Kanter; Michael Schaffer; Ann Dunnigan; Steven Colan; Gerald Serwer
Journal:  Heart Rhythm       Date:  2004-07       Impact factor: 6.343

6.  Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry.

Authors:  J D Kugler; D A Danford; K Houston; G Felix
Journal:  Am J Cardiol       Date:  1997-12-01       Impact factor: 2.778

7.  Success rates in pediatric WPW ablation are improved with 3-dimensional mapping systems compared with fluoroscopy alone: a multicenter study.

Authors:  Scott R Ceresnak; Anne M Dubin; Jeffrey J Kim; Santiago O Valdes; Steven B Fishberger; Ira Shetty; Frank Zimmerman; Ronn E Tanel; Michael R Epstein; Kara S Motonaga; Christine A Capone; Lynn Nappo; Gregory J Gates; Robert H Pass
Journal:  J Cardiovasc Electrophysiol       Date:  2015-03-05

8.  Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes.

Authors:  George F Van Hare; Harold Javitz; Dorit Carmelli; J Philip Saul; Ronn E Tanel; Peter S Fischbach; Ronald J Kanter; Michael Schaffer; Ann Dunnigan; Steven Colan; Gerald Serwer
Journal:  J Cardiovasc Electrophysiol       Date:  2004-07

9.  Prospective assessment after pediatric cardiac ablation: fate of intracardiac structure and function, as assessed by serial echocardiography.

Authors:  George F Van Hare; Steven D Colan; Harold Javitz; Dorit Carmelli; Timothy Knilans; Michael Schaffer; John Kugler; Craig J Byrum; J Philip Saul
Journal:  Am Heart J       Date:  2007-05       Impact factor: 4.749

10.  Permanent pacemaker implantation for late atrioventricular block in patients receiving catheter ablation for atrioventricular nodal reentrant tachycardia.

Authors:  Jo-Nan Liao; Yu-Feng Hu; Tsu-Juey Wu; Ann-Ning Fong; Wei-Shiang Lin; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Ta-Chuan Tuan; Hung-Yu Chang; Cheng-Hung Li; Tze-Fan Chao; Fa-Po Chung; Dicky Armein Hanafy; Wen-Yu Lin; Jin-Long Huang; Chin-Chou Huang; Hsin-Bang Leu; Pi-Chang Lee; Chern-En Chiang; Shih-Ann Chen
Journal:  Am J Cardiol       Date:  2012-12-04       Impact factor: 2.778

View more
  1 in total

1.  Incidence of Echocardiographic Abnormalities Following Pediatric SVT Ablation: Comparison of Cases Utilizing Fluoroscopy Alone to Cases with Adjunctive 3D Electroanatomic Mapping.

Authors:  Ari J Gartenberg; Robert H Pass; Scott Ceresnak; Lynn Nappo; Christopher M Janson
Journal:  Pediatr Cardiol       Date:  2018-10-12       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.